Moderna says its COVID vaccine candidate offers immunity for up to three months after the second dose.
The biotech company says adults ages 18 to 55 saw the highest levels of antibodies, followed by people over 71, and those between the ages of 56 and 70.
The vaccine still awaits emergency approval from the FDA.
READ MORE: FDA announces advisory committee meeting to discuss Moderna vaccine candidate
FOX 5’s Shirin Rajaee checked in with Moderna vaccine participants in Phase 3 trials at George Washington University.
“I feel great, I think I got the vaccine, and I feel liberated. I haven’t been doing much, but I actually felt empowered to visit family over Thanksgiving,” said GW professor and vaccine participant Bill Adams.
Adams says he knew there was a lot of uncertainty, but says the risk of getting COVID was greater.
“I didn’t feel I was sticking my neck out because the Phase 1 trials, everyone developed antibodies, and in Phase 2, not a single person had bad side effects,” said Adams.
Vanessa Ferragut, 43, says she was uncertain whether or not she received the vaccine or the placebo. But if the vaccine was available today, she said she would absolutely take it.
Yet, many in the African American and Hispanic communities are hesitant about a vaccine.
Maybe they should check in on Giuliani, who in an epic bout of cosmic karma, has infected himself and God knows how many others with COVID-19. This is why you wear a mask idiots.
Does this mean multiple shots per year?
No thank you!
Just wait until the side effects of the Vaccine start to kick in.
Some of the test subjects have already died.
This is also the danger of sterility for young women who take the Vaccine and
for those who are already pregnant.